WhoCrSurveillanceDataDictionary

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

• value @ url

Attributes of the case report

Date of reporting

Country/territory/national boundary (admin level 0) within which the case currently/usually resides. If transborders or international spread of outbreak

Why the case was tested for COVID-19

Case patient demographics

Unique case identification number (used in country)

Age on the date of illness onset

Biological sex. That is the biological differential characteristics (chromosomes, hormonal profiles, internal and external sex organs) that best describes the case.

Details of the diagnosis of the case

Country (administrative level 0) where the case was diagnosed.

First sub-national boundary (e.g. province, state, territory, prefecture, region, etc.) (administrative level 1) where the case was diagnosed.

Details of the residence of the case

Country (administrative level 0) within which the case's currently/usually resides.

Clinical status of the case on admission

Details of case lab testing

Date of first laboratory confirmation

Details of the course of treatment of the case

Date of first appearance of the signs or symptoms of the illness/disease.

Is the case asymptomatic?

Was the case hospitalized, admitted to a hospital or other health facility as an inpatient?

Date the case was first admitted to any health facility.

Did the patient receive care in an intensive care unit (ICU)?

Was the patient ever ventilated for this episode at time of reporting?

Did the patient receive extracorporeal membrane oxygenation (ECMO)?

Was the case isolated with proper IPC controls implemented?

What date was the case isolated?

Conditions and co-morbidities of the case

Does the patient have any underlying conditions?

Co-morbidities or conditions is the case known to have. Note that limited inferences may be made about conditions not asserted: the patient may not have the condition; the submitter (or patient) may not know if the patient has the condition; at the time the response was submitted, the condition was not included in the list.

Trimester of pregancy

Potential exposure

Details of patient related to exposure

Exposure via patient healthcare employment details

Is the patient working in a health care setting?

Healthcare worker facility details

If case is a healthcare worker, in which country do they work?

If case is a healthcare worker, in which city do they work?

If case is a healthcare worker, what is the name of the facility in which they work?

Exposure via travel details

Has the patient travelled in the 14 days prior to symptom onset?

Locations of travel in the 14 days prior to symptom onset

Specify country of travel for this location

Specify city travelled to for this location

Specify dates at this location

Has the patient visited any health care facilities in the 14 days prior to symptom onset

Patient exposure to confirmed cases

Has the patient had contact with a confirmed case in the 14 days prior to disease onset?

Confirmed case contact

Unique identifier of confirmed case with whom the patient had contact

Details of exposure to confirmed case

Dates of exposure to confirmed case

If the patient has had contact with a confirmed case in the 14 days prior to symptom onset, explain contact setting

Specify the location of possible exposure to a case

Patient outcome

Has the outcome section been submitted?

Date of outcome submission

If case was asymptomatic at time of specimen collection resulting in first laboratory confirmation, did the case develop any symptoms or signs at any time prior to discharge or death

If case was asymptomatic and developed symptoms, what is the date of onset for symptoms/signs of illness

Details of the outcome of the patient course of treatment

Patient was first admitted to hospital (outcome)

Date patient was first admitted to hospital (outcome)

Did the patient receive care in an intensive care unit (ICU)? (outcome)

Was the patient ever ventilated for this episode? (outcome)

Did the patient receive extracorporeal membrane oxygenation (ECMO)? (outcome)

Patient status (outcome)

Date of Release from isolation/hospital or Date of Death

If released from hospital /isolation, details of last laboratory test

Date of last laboratory test

Result of last test

High risk contacts followed from this case

Total number of high-risk contacts followed for this case

Number of high risk contacts followed unknown